First Once-Weekly Basal Insulin Approved for Type 2 Diabetes

(MedPage Today) -- The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults with type 2 diabetes, developer Novo Nordisk announced. Of note, the agency rejected the product in...